Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
epigenetics
Biotech
Scribe notes IPO plan to push lipid-lowering meds through clinic
Scribe is the latest biotech to prepare a public listing, as the company looks to propel its lipid-lowering medicines through clinical trials.
James Waldron
Jul 6, 2026 7:54am
Epicrispr gene silencer enhances muscle in muscular dystrophy
Jun 26, 2026 10:40am
Anti-aging biotech NewLimit nabs $435M to rejuvenate old cells
Jun 2, 2026 1:00pm
Kazia pays research institute $1.4M for epigenetic platform
Apr 14, 2026 10:04am
Scribe eyes clinic as CRISPR candidates lower lipids in animals
Nov 17, 2025 9:22am
nChroma Bio sheds staff in research reorganization
Nov 12, 2025 5:31pm
